ABSTRACT In a study of a cohort of 2498 men and 1032 women employed in the manufacture of mustard gas in Cheshire during the second world war 3354 (95%) individuals were successfully traced for mortality to the end of 1984. Large and highly significant excesses were observed as compared with national death rates for deaths from cancer of the larynx (11 deaths observed, 4 04 expected, p = 0-003), pharynx (15 observed, 2-73 expected, p < 0 001), and all other buccal cavity and upper respiratory sites combined (lip, tongue, salivary gland, mouth, nose) (12 observed, 4-29 expected, p = 0-002). For lung cancer, a highly significant but more moderate excess was observed (200 observed, 138-39 expected, p < 0 001). Significant excesses were also observed for deaths from acute and chronic non-malignant respiratory disease (131 observed, 91 87 expected and 185 observed, 1 16-31 expected, respectively). The risks for cancers ofthe pharynx and lung were significantly related to duration ofemployment. None of these results is substantially altered when expected numbers are calculated from Cheshire urban areas rather than national rates, although the relative risks for lung cancer and non-malignant respiratory disease are substantially reduced if rates for Merseyside, the nearest large conurbation, are used. The results provide strong evidence that exposure to mustard gas can cause cancers of the upper respiratory tract and some evidence that it can cause lung cancer and non-malignant respiratory disease. Significant excess mortality was also observed for cancers of the oesophagus (20 observed, 10-72 expected) and stomach (70 observed, 49 57 expected) but these excesses showed no consistent relation with time since first exposure or duration ofexposure, and it is not clear whether they were caused by mustard gas or were due to a combination of chance and confounding.
Mustard gas (bis-2-chloroethyl sulphide) was first manufactured for use in the first world war when many hundreds of thousands of soldiers were poisoned by it.' Subsequently, the compound was found to be mutagenic in bacteria and carcinogenic in laboratory animals2 and exposure to it was thought to be a possible cause of cancer in man.
Two types ofexposure have been investigated: acute exposure resulting from use of the gas in war and chronic exposure in the course of its manufacture. The results of the first have been equivocal. British soldiers who received a pension for mustard gas poisoning were found to have a raised mortality from lung cancer; but most of these men also had chronic bronchitis and a similar excess of lung cancer was Accepted 18 January 1988 found in pensioners with bronchitis who had not been exposed to the gas.3 United States veterans with mustard gas injury had a clearly increased mortality from pneumonia but only a slight and statistically not significant increase in mortality from lung cancer. '4 Two studies of the effects of occupational exposure to mustard gas have provided evidence of a cancer hazard. Wada et al reported 33 deaths from respiratory cancer in Japanese workers who manufactured mustard gas and other poisons on the island of Okunojima between 1929 and 1945 when only 09 would have been expected, but few details were given of the exposed cohort and it is difficult to judge the reliability of the comparison.5 In the other study Manning et al reported an excess of laryngeal cancer (7 cases compared with 075 expected) and an increased mortality from cancer of the lung and pneumonia in 511 men who worked in a mustard gas 652
Cancers ofthe respiratory tract in mustard gas workers factory in Cheshire during the second world war. 6 The cohort studied by Manning et al constituted, however, only a small proportion of the total number of employees at this factory during the period mustard gas was manufactured. We have, therefore, reexamined the factory's engagement and discharge registers and carried out a more extensive study.
Population and methods

FACTORY
The factory, commissioned in April 1938, produced toxic gases (none of which was in fact used) until November 1944. Twenty four thousand tonnes of mustard gas and about 1000 tonnes of Larmine, a lachrymatory mixture of 70% bromobenzyl cyanide and 30% benzyl cyanide, were manufactured. Various arsenic compounds were also stored at the site but not manufactured there.
Gas escaped on several occasions and several hundred individuals suffered acute effects caused by small amounts ofmustard gas, principally in the actual process plants. No The date of first engagement was in some cases taken from the employment records of a nearby works operated by the same company as some workers were recruited via this works to the factory without being recorded on the factory engagement register. The 396 workers for whom no record of recruitment at either works could be found were assumed to have been engaged in April 1938, when the factory opened. Production of mustard gas started soon afterwards, and for the purposes of assessing the effect of time 653 since first exposure and duration of exposure, exposure was taken to start on 1 July 1938 or the date of engagement (if later) and to cease on 30 November 1944 or the date of discharge (whichever was the earlier).
Many of the 2096 women worked for relatively short periods, mainly in jobs with little exposure to mustard gas. The 1044 women with less than one year's service were therefore excluded. The 745 men with less than one year's service were, however, retained as many of them were employed in process areas. Follow up began on 1 January 1945 and individuals whose names appeared in the engagement register entered the study on this date. Those appearing only on the discharge register entered the study on their date of discharge, or on 1 January 1945, whichever was the later.
FOLLOW UP
The cohort was traced through the National Health Service Central Register (NHSCR) ( controls whose job at entry was specified suggested that process workers suffered a substantially higher risk than other workers. There was little or no difference between the other four groups (tradesmen in process areas, workshop jobs, labourers, others) and in subsequent analyses workers were therefore classified as process or non-process. The present analysis also showed a consistent increase in risk with total duration of employment.
Workers specified as process workers on the discharge register showed a somewhat increased risk but the effect was less pronounced than that based on the job at entry.
COHORT ANALYSIS: DURATION OF EMPLOYMENT AND TIME SINCE FIRST EMPLOYMENT
Further cohort analysis has been restricted to causes of death showing excess mortality by comparison with national or local rates-namely, cancers of the pharynx, larynx, other buccal cavity, and upper respiratory tract sites (comprising lip, tongue, salivary gland, mouth, and nose), lung, oesophagus, stomach, and non-malignant respiratory disease. These analyses have been restricted to men, since women contribute little to the total excess. Table 4 shows the observed and expected numbers of deaths by duration of employment and time since first employment. The SMR is higher in workers employed for three or more years than in those employed for less than three years by a factor of for cancer of the pharynx and by factors of 1-4, 1-3, and 1 4 for cancers of the larynx, lung, and other upper respiratory tract sites, though the difference in SMR is significant only for cancers of Table 5 Observed (0) and expected (E) deathsfrom selected causesfor workers specified as process workers (PR), nonprocess workers (NP), or not specified (NS) at entry by duration ofemployment Duration ofemployment (years) There are too few deaths from the other cancers shown in tables 4 and 5 for detailed analysis, but none shows any obvious trend in risk with time since first employment.
Discussion
Our observations are (with one proviso) broadly consistent with those on Japanese mustard gas workers who were heavily exposed between 1929 and 1945, in whom Wada and his colleagues found five cancers of the larynx, 20 of the bronchus or lung, one of the trachea, three of the pharynx, one of the tongue, and three of the paranasal sinuses by comparison with an expected total of 0-9.5 The SMRs were much lower in our cohort, particularly for cancer of the lung; but it should be noted that Japanese cigarette consumption was low until the 1950s and Japanese mortality from cancer ofthe lung was therefore also low until after the 1960s. There is no material difference between our data and the Japanese results in the distribution among these sites of the absolute excess of observed deaths over expected. Our results and those of Wada et al, are, therefore, broadly consistent on the assumption that the hazard of lung cancer produced by exposure to mustard gas adds to rather than multiplies the risk due to smoking. This would imply a substantial risk of lung cancer among non-smokers but in the Cancers of the respiratory tract in mustard gas workers 657 658 absence of any data on smoking we cannot test this prediction. Apart from the excess of laryngeal cancer observed in the earlier study of workers at this factory,' no increased risk of cancer has been clearly shown in either workers or servicemen exposed to mustard gas outside Japan, but neither the Japanese study nor the previous study of this factory was based on complete factory records. The excesses of cancers of the pharynx, larynx, and other upper respiratory tract sites observed in our cohort are too large to be accounted for by confounding factors, increased with duration of employment and were limited to the period more than 10 years after first employment, when the risk was increased fourfold. There can, therefore, be no doubt that cancers in these sites were caused by the exposure, though the number of deaths at individual sites, other than the pharynx and larynx, are too small to be sure that all were equally (or indeed at all) at risk.
In terms of absolute risk the excess of the lung cancer is more important, since lung cancers account for more than half the overall excess over expected for respiratory cancers. Much of this excess could be accounted for by the use ofnational or Cheshire urban district rates for comparison rather than the rates for Merseyside; but the Japanese results, together with the fact that the SMR was greatest in workers employed for three years or more, suggest that some ofthe excess was likely to have been real.
The choice of appropriate comparison mortality rates represents a serious difficulty in this study, particularly in interpreting the excesses of cancers of the lung, stomach, and oesophagus and of non-malignant respiratory disease. For each of these causes of death Merseyside has had exceptionally high rates during the period of this study, whereas Cheshire urban rates are more similar to the national rates. The works were on the south bank of the Mersey about 15 miles from Liverpool. When a random sample of 203 of the addresses of individuals on the discharge register were examined only 42 (21%) fell within the Merseyside conurbation, with 74 (38%) in Cheshire urban areas and 87 (43%) in rural Cheshire, Lancashire, and elsewhere (where the rates for the above diseases, as in Cheshire urban districts, were not exceptionally high).
Thus if no migration had occurred the Merseyside rates should have had only a relatively small impact on the mortality ofthe cohort. It is thought, however, that a proportion of the workforce were attracted from Merseyside to work in the factory. The extent to which this could have influenced the underlying mortality is unknown, but it is reasonable to assume that the appropriate SMRs lie somewhere between those obtained from national and Merseyside rates. Such an adjustment could substantially alter the pattern of Easton, Peto, Doll absolute excess risk of lung cancer in relation to time since first exposure, as expected numbers were calculated from national rates. We cannot, therefore, use our results to formulate reliable incidence models either for lung cancer or for buccal and upper respiratory cancers. The excess risk of lung cancer is only moderate and the comparison rates are uncertain, whereas for these other sites the total number ofdeaths is small.
The risk of respiratory cancer was not notably localised to individuals employed in process areas, which may indicate that the risk of cancer was due more to ambient levels of mustard gas in the factory than to the high levels to which process workers were exposed for short periods.
Quite substantial excesses were observed for two sites for which no previous evidence of a risk ofcancer in mustard gas workers had been suspected-namely, oesophagus and stomach. Neither showed any positive relation with duration or type ofwork and for cancer ofthe oesophagus the excess was greater in men who were employed for less than three years than in men who had been employed for longer. These sites deserve consideration in any future studies, but our data do not provide convincing evidence that these cancers may be caused by mustard gas.
The excess mortality from non-malignant respiratory disease is difficult to interpret. The SMRs for both chronic bronchitis and acute respiratory disease would be substantially reduced, to 114 and 108 respectively, if the Merseyside population were the appropriate comparison group. In normal circumstances chronic bronchitis is almost exclusively confined to cigarette smokers,'4 and an increased risk could be accounted for if smokers were overrepresented in this workforce. In addition there is the possibility that an initially unhealthy workforce was selected, perhaps due to wartime employment factors; this might have much more impact on nonmalignant respiratory disease than on cancer mortality. Against this, the excess of chronic bronchitis is consistent with the excess observed in British soldiers pensioned after mustard gas poisoning3 and the excess of acute respiratory deaths with that observed in the United States first world war veterans.' On balance, some of the excess mortality from respiratory disease was probably the result of exposure to mustard gas but the magnitude of the risk is uncertain.
